Red ListRecovering

KROSKeros Therapeutics, Inc.

Healthcare · Biotechnology · micro-cap ($219M)
-52.7%
from rolling 252-day high of $22.55 set 2025-12-08 · 312d ago
Current
$10.66
Decline depth
-52.7%
Decline σ
5.5σ
TFC
2/5 bearish

Where it stands

On the Red List.

Down 52.7% from its rolling 252-day high, 312 days after the high.

Snapshot . Price structure, not a judgment about the business.

A bullish structural signal is also active. The Recovering badge coexists with the decline tier; it does not establish a completed recovery.

What changed

Since the previous observation.

Tier and recovery signal are unchanged between these two observations.

Comparing with . This compares classification, not price returns.

See the recorded timeline →

Why it is flagged

KROS qualifies for the Red List on decline depth.

Down 52.7% from its rolling 252-day high, 312 days after the high. The most severe triggered rule determines the tier.

Inspect the three classification measures
Decline depth
-52.7%
From rolling 252-day high of $22.55, 312d ago. Past the 40% Red List threshold.
Time-frame continuity
2/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
5.5σ
Drop over the last 10 bars in units of daily volatility (2.42%/day). Past the ≥4σ Watch threshold.

Price history

The price path behind the snapshot.

Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.

Rolling 252-day high Gold dots: recorded classification events (see timeline) Up day Down day 90 daily bars from Alpaca · through

The recorded history

A timeline of observations.

First observed 2026-05-15. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.

  1. Red List → Red List; recovery signal active
  2. Red List; recovery signal active → Red List
  3. Red List → Red List; recovery signal active
  4. Red List; recovery signal active → Red List
  5. Unmatched; coverage or recovery unconfirmed → Red List; recovery signal active
  6. Red List → Unmatched; coverage or recovery unconfirmed
  7. Red List; recovery signal active → Red List
  8. Red List → Red List; recovery signal active
  9. Watch → Red List
  10. Red List → Watch
  11. Red List; recovery signal active → Red List
  12. Red List → Red List; recovery signal active

Showing the latest 12 of 30 recorded events.

Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.

Technical interpretation and signal details

The structural read

What price action says about KROS.

KROS qualifies for the Red List on decline depth — down -52.7% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: decline sigma also reads 5.5σ over 10 bars.

A confirmed bullish signal on one or more time frames earned the Recovering badge. The tier reflects the most severe price-structure rule; Recovering identifies a separate bullish signal. Not a buy signal.

Whether KROS's turn is investable is ConvictionEdge's question, not ours.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 3 (red).

Earnings on file: 2026-08-03. Earnings dates don't affect tiering.

Questions about KROS

What people ask.

Why is KROS on Broken Stocks?

KROS qualifies for the Red List on decline depth. It is down -52.7% from its rolling 252-day high of $22.55, set on 2025-12-08 — 312d ago. It additionally carries a Recovering badge — see below.

What does the Recovering badge mean for KROS?

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — KROS is still Red List because a price-structure rule still triggers, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier reflects the most severe triggered rule; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

Is KROS a falling knife?

Not by the strict technical definition. KROS is down -52.7% from its 52-week high, but that high was set 312d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. KROS is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is KROS a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is KROS trading inside its 52-week range?

At $10.66, KROS sits 7.5% of the way from its 52-week low ($9.69) to its 52-week high ($22.55). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has KROS been declining?

The current 52.7% decline accrued over 312d, which annualizes to roughly -61.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does KROS compare to its sector?

There are 408 other Healthcare tickers on Broken Stocks: 273 Red, 95 Amber, 40 Watch, with 177 showing recovering structural signals. Median sector decline is -37.5% — KROS's decline is deeper than the sector median.

Does KROS's earnings date affect its tier?

No. Tiering uses decline depth and recency, bearish time-frame structure, and decline sigma. The earnings date on file (2026-08-03) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.